Mdb capital collaborates with mayo clinic to advance anti-senescence platform

Addison, texas, july 08, 2024 (globe newswire) -- mdb capital holdings, llc, (nasdaq: mdbh) (“mdb”), a public venture platform focused on launching category-leading deep technology companies, today announced a collaboration through a patent and know-how agreement with mayo clinic to develop a small molecule anti-senescence platform. this collaboration aims to advance research in longevity and age-related disease prevention.
MDBH Ratings Summary
MDBH Quant Ranking